Stuart A. Arbuckle, EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,781 shares at $212.77 ($594K) on 2021-02-03, disclosed to the SEC on 2021-02-05.
Seasonal sale ($594k) by EVP, Chief Commercial Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $211.22 | 148 | $31K | 5.3% |
| 2 | $212.77 | 488 | $104K | 17.5% |
| 3 | $212.77 | 488 | $104K | 17.5% |
| 4 | $213.90 | 497 | $106K | 17.9% |
| 5 | $213.90 | 497 | $106K | 17.9% |
| 6 | $214.98 | 242 |
| $52K |
| 8.8% |
| 7 | $214.98 | 242 | $52K | 8.8% |
| 8 | $215.80 | 90 | $19K | 3.3% |
| 9 | $216.83 | 89 | $19K | 3.2% |
| Total | $213.70 avg | 2,781 | $594K | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |